Back to Search Start Over

104P Safety and efficacy of HLX04 versus reference bevacizumab in combination with XELOX or mFOLFOX6 as first-line treatment for metastatic colorectal cancer: A randomised, double-blind phase III study.

Authors :
Qin, S.
Li, J.
Bai, Y.
Shu, Y.
Li, W.
Yin, X.
Cheng, Y.
Sun, G.
Deng, Y.
Zhong, H.
Li, Y.
Qian, X.
Zhang, L.
Zhang, J.
Chen, K.
Jiang, W.
Liu, S.
Chai, K.
Source :
Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1282-S1282. 1p.
Publication Year :
2020

Subjects

Subjects :
*BEVACIZUMAB
*COLORECTAL cancer
*CANCER treatment

Details

Language :
English
ISSN :
09237534
Volume :
31
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152684637
Full Text :
https://doi.org/10.1016/j.annonc.2020.10.124
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details